Tranquili-Tea is formulated to help people fall and stay asleep. CBN produces a sedative and relaxing effect that induces sleep, while THC increases sleep duration. Our herb blend includes chamomile and valerian root, which have been used throughout time as sleep agents.
5mg CBN / 3mg THC per individual sachet Each pouch contains 1 sachet
Suggested Uses: - The unique cannabinoid ratio helps users fall and stay asleep - Synergistic herbs relieve anxiety and have sedative effects - For less nighttime fluid, steep in half the water (potency the same) - Best drunk 60 minutes before lights out - May help migraines
Tranquili-Tea is formulated to help people fall and stay asleep. CBN produces a sedative and relaxing effect that induces sleep, while THC increases sleep duration. Our herb blend includes chamomile and valerian root, which have been used throughout time as sleep agents.
5mg CBN / 3mg THC per individual sachet Each pouch contains 1 sachet
Suggested Uses: - The unique cannabinoid ratio helps users fall and stay asleep - Synergistic herbs relieve anxiety and have sedative effects - For less nighttime fluid, steep in half the water (potency the same) - Best drunk 60 minutes before lights out - May help migraines
No product reviews
Have you tried this product? Be the first to leave a review!
Kikoko is a women-owned, women-run company inspired by a friend who battled cancer. Our founders noticed a lack of properly dosed edibles with high-quality ingredients, and they set out with a mission to create alternatives to pharmaceuticals and alcohol. Our organic, clinically dosed, cannabis-infused products are for people who value wellness and high-quality ingredients. Kikoko makes herbal teas, tinctures, mints, and HoneyShots. Based on clinical research, each product line is designed to solve a problem, pairing thoughtful cannabinoid ratios, synergistic herbs, vitamins, and adaptogenic ingredients for sleep, anxiety, mood, sex, and pain. We are committed to sustainability and making an impact, and we donate a portion of our annual revenue to initiatives that promote cannabis research and reform, such as the Last Prisoner Project.
